LONDON, UK — 5 June, 2020 — LogRhythm, the company powering today’s security operations centres, today announced that its NextGen SIEM Platform received the SC Awards Europe 2020 accolade for Best SIEM Solution. Due to the current lockdown measures being undertaken globally, the awards were held digitally. This award follows the organisation’s recent receipt of several honours, including the CDM InfoSec Awards for Best SIEM and User Behaviour Analytics Market Leader, as […]

(London UK, June 4, 2020) Global research company OMDIA – formerly known as Ovum – has today released the first version of its 5G Market Progress Assessment (end-2019) report, showing that South Korea is the leading country for 5G deployment in the twenty two leading 5G countries analyzed for their deployment of 5G technology. The OMDIA research assessed the deployment progress of 5G based on operator launches, network coverage, subscriber take-up as well as 5G... Source: RealWire

(London UK, June 4, 2020) Global research company OMDIA – formerly known as Ovum – has today released the first version of its 5G Market Progress Assessment (end-2019) report, showing that Switzerland and the UK are leading the way in Europe of the twenty two leading 5G countries analyzed for their deployment of 5G technology. The OMDIA research assessed the deployment progress of 5G based on operator launches, network coverage, subscriber take-up as well as... Source: RealWire

Perforce customers Intrasoft and SBM have saved a combined 17,254 hours of Java development time since adopting the JRebel developer productivity tool. MINNEAPOLIS, June 4, 2020 – Perforce Software, a provider of solutions to enterprise teams requiring productivity, visibility, and scale along the development lifecycle, today announced that its customers are seeing record time savings with JRebel, the developer productivity tool for Java teams. By using JRebel by Perforce, a technology […]

New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome[1] World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology[2] Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving […]